In the news release, Obagi Medical Introduces New CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads Designed to Resurface, Clarify, and Visibly Brighten Skin, issued 18-Aug-2026 by Obagi Medical over PR Newswire, we are advised by the company that an edit was made. The complete, corrected release follows:

Obagi Medical Introduces New CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads Designed to Resurface, Clarify, and Visibly Brighten Skin

A multi-acid treatment to resurface and visibly brighten skin through depth-targeted exfoliation powered by each acid’s unique molecular weight.

NEW YORK, Aug. 18, 2026 /PRNewswire/ — Obagi Medical (“Obagi”), a leader in advanced skincare innovation and the originator of medical-grade skincare, today announced the launch of its new CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads.

Obagi Medical CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads are formulated with a high-performance blend of 4% Glycolic, 3% Phytic, 2% Salicylic, and 1% Mandelic acids, each selected for its targeted action at a different layer of the skin. Together, the acids deliver multi-tiered exfoliation that smooths skin texture, decongests and minimizes the appearance of pores, reduces the look of discoloration, and visibly brightens dull skin for a more radiant, even-toned complexion.

“Effective exfoliation is the foundation of optimal skin health,” said Dr. Suzan Obagi. “These peel pads make it easy to build consistent, targeted exfoliation into a PM routine, helping reveal visibly smoother, brighter, more even-toned skin over time.”

In a clinical study, 97% of participants agreed the CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads visibly smoothed skin texture after four weeks. By eight weeks, 90% noticed their skin looked smoother, 83% saw their breakouts and blemishes improve, and the majority of participants noticed brighter-looking skin with a reduced appearance of post-blemish marks.

“We’re committed to developing clinically proven skincare solutions that meet the evolving needs of both providers and patients,” said Dorothée Dufour, Senior Vice President of Global & Brand Marketing. “These peel pads mark an exciting expansion of the CLENZIderm M.D.® franchise, giving consumers an easy, one-step way to bring dermatologist-trusted resurfacing into their everyday routine.”

Whether used on their own or alongside a broader routine, the peel pads give consumers a clinically backed way to achieve visibly smoother, brighter skin without leaving home.

CLENZIderm M.D.® Resurfacing Multi-Acid Peel Pads are now available for $100 on Obagi.com, Amazon.com, as well as through authorized Obagi Medical providers and select retail channels.

About Obagi Medical
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024*. Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand’s website, https://www.obagi.com/.

Correction: Justin Giouzepis’ quote was updated.

View original content to download multimedia:https://www.prnewswire.com/news-releases/obagi-medical-introduces-new-clenziderm-md-resurfacing-multi-acid-peel-pads-designed-to-resurface-clarify-and-visibly-brighten-skin-302853736.html

SOURCE Obagi Medical